<VariationArchive VariationID="550322" VariationName="NM_001164508.2(NEB):c.9465del (p.Ile3156fs)" VariationType="Deletion" Accession="VCV000550322" Version="16" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-06-17" DateCreated="2018-08-05" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="541524" VariationID="550322">
      <GeneList>
        <Gene Symbol="NEB" FullName="nebulin" GeneID="4703" HGNC_ID="HGNC:7720" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151485339" stop="151734476" display_start="151485339" display_stop="151734476" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152341852" stop="152591000" display_start="152341852" display_stop="152591000" Strand="-" />
          </Location>
          <OMIM>161650</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001164508.2(NEB):c.9465del (p.Ile3156fs)</Name>
      <CanonicalSPDI>NC_000002.12:151631295:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151631296" stop="151631296" display_start="151631296" display_stop="151631296" variantLength="1" positionVCF="151631295" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152487810" stop="152487810" display_start="152487810" display_stop="152487810" variantLength="1" positionVCF="152487809" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>I3156fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.1" sequenceAccession="NM_001271208" sequenceVersion="1" change="c.9465del">
            <Expression>NM_001271208.1:c.9465del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.152487813del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.152487813del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.151631299del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.151631299del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009382.2" sequenceAccession="NG_009382" sequenceVersion="2" change="g.108192del">
            <Expression>NG_009382.2:g.108192del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164507.2" sequenceAccession="NM_001164507" sequenceVersion="2" change="c.9465del" MANEPlusClinical="true">
            <Expression>NM_001164507.2:c.9465del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157979.2" sequenceAccession="NP_001157979" sequenceVersion="2" change="p.Ile3156fs">
            <Expression>NP_001157979.2:p.Ile3156fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164508.2" sequenceAccession="NM_001164508" sequenceVersion="2" change="c.9465del" MANESelect="true">
            <Expression>NM_001164508.2:c.9465del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157980.2" sequenceAccession="NP_001157980" sequenceVersion="2" change="p.Ile3156fs">
            <Expression>NP_001157980.2:p.Ile3156fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.2" sequenceAccession="NM_001271208" sequenceVersion="2" change="c.9465del">
            <Expression>NM_001271208.2:c.9465del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258137.2" sequenceAccession="NP_001258137" sequenceVersion="2" change="p.Ile3156fs">
            <Expression>NP_001258137.2:p.Ile3156fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004543.5" sequenceAccession="NM_004543" sequenceVersion="5" change="c.8854-118del">
            <Expression>NM_004543.5:c.8854-118del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_202" sequenceAccession="LRG_202">
            <Expression>LRG_202:g.108192del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_202t1" sequenceAccession="LRG_202t1">
            <Expression>LRG_202t1:c.9465del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164507.1" sequenceAccession="NM_001164507" sequenceVersion="1" change="c.9465delC">
            <Expression>NM_001164507.1:c.9465delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1553939600" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001164508.2(NEB):c.9465del (p.Ile3156fs) AND Nemaline myopathy 2" Accession="RCV000665042" Version="11">
        <ClassifiedConditionList TraitSetID="3882">
          <ClassifiedCondition DB="MedGen" ID="C1850569">Nemaline myopathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-12-09" SubmissionCount="5">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.9465del (p.Ile3156fs) AND Nemaline myopathy" Accession="RCV002222585" Version="1">
        <ClassifiedConditionList TraitSetID="12233">
          <ClassifiedCondition DB="MedGen" ID="C0206157">Nemaline myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.9465del (p.Ile3156fs) AND not provided" Accession="RCV002285395" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.9465del (p.Ile3156fs) AND Arthrogryposis multiplex congenita 6" Accession="RCV004568487" Version="1">
        <ClassifiedConditionList TraitSetID="66961">
          <ClassifiedCondition DB="MedGen" ID="C5543431">Arthrogryposis multiplex congenita 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-18" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2018-08-05" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25205138</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32222963</ID>
        </Citation>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3882" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5618" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy 2, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy caused by mutation in the nebulin gene</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy 2</ElementValue>
                <XRef ID="Nemaline+myopathy+2/5124" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009725" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEM2</ElementValue>
                <XRef Type="MIM" ID="256030" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15209" />
                <XRef ID="15209" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22510848</ID>
              </Citation>
              <XRef ID="C1850569" DB="MedGen" />
              <XRef ID="MONDO:0009725" DB="MONDO" />
              <XRef Type="MIM" ID="256030" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="66961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="56163" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Arthrogryposis multiplex congenita 6</ElementValue>
                <XRef ID="MONDO:0030281" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMC6</ElementValue>
                <XRef Type="MIM" ID="619334" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543431" DB="MedGen" />
              <XRef ID="MONDO:0030281" DB="MONDO" />
              <XRef Type="MIM" ID="619334" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12233" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9537" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myopathies, Nemaline</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rod myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy</ElementValue>
                <XRef ID="MONDO:0018958" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
                <XRef ID="75072002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12033" />
                <XRef ID="12033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="607" DB="Orphanet" />
              <XRef ID="C0206157" DB="MedGen" />
              <XRef ID="MONDO:0018958" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1539403" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="455079|OMIM:256030" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000789099" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="T" referenceAllele="TG" start="152487809" stop="152487810" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.9465delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256030" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4068030" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_001271208.2:c.9465del|Nemaline myopathy type 2" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002077167" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.2:c.9465del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nemaline myopathy type 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2717844" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4833703|MedGen:C1850569" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001383047" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 550322). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with nemaline myopathy (PMID: 25205138). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ile3156Leufs*16) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.152487810del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850569" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4890951" SubmissionDate="2022-04-19" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_001271208.1:c.9465delC|MedGen:C0206157" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002500327" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Comment>Variant summary: NEB c.9465delC (p.Ile3156LeufsX16) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 248870 control chromosomes (gnomAD). c.9465delC has been reported in the literature in an individual affected with Nemaline Myopathy (Lehtokari_2014). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic (n=1) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.9465delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0206157" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350627</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5002386" SubmissionDate="2022-12-11" DateLastUpdated="2022-12-17" DateCreated="2022-08-04">
        <ClinVarSubmissionID localKey="sa_pathology/molecular_genetics_frome_rd/vc14473" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002556432" DateUpdated="2022-12-17" DateCreated="2022-08-04" Type="SCV" Version="2" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PM2, PS4_supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_4068</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001164507.1:c.9465delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256030" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_33</SubmissionName>
          <SubmissionName>submission_36</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5415425" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001271208_1_NEB_c_9465delC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768813" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32222963</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with nemaline myopathy (MIM#256030). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0219 - This variant is non-coding in an alternative transcript. However, many pathogenic variants in the same coding exon have been reported (ClinVar, UCSC). (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (PMID: 32222963, ClinVar). (SP) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. This variant has been reported as likely pathogenic (ClinVar), and in a compound heterozygous patient with severe nemaline myopathy (PMID: 25205138). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant (p.Arg8094Serfs*9) in a recessive disease. (SP) 1206 - This variant has been shown to be paternally inherited (19G000860). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_4068</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.9465delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256030" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5035449" SubmissionDate="2022-09-28" DateLastUpdated="2023-03-04" DateCreated="2022-10-01">
        <ClinVarSubmissionID localKey="GDXSV:241407" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002576050" DateUpdated="2023-03-04" DateCreated="2022-10-01" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Identified in the presence of a second NEB variant, phase unknown, in a patient with a form of NEB-related nemaline myopathy characterized by pronounced weakness of axial muscles with relative sparing of limb muscles in the published literature (Lehtokari et al., 2014); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25205138)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:734732</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.9465del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_132_20220928054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9812053" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_001271208.1:c.9465del|OMIM:619334" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005056256" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.9465del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619334" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5035449" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5415425" TraitType="Disease" MappingType="XRef" MappingValue="256030" MappingRef="OMIM">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4890951" TraitType="Disease" MappingType="XRef" MappingValue="C0206157" MappingRef="MedGen">
        <MedGen CUI="C0206157" Name="Nemaline myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4068030" TraitType="Disease" MappingType="Name" MappingValue="Nemaline myopathy type 2" MappingRef="Preferred">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1539403" TraitType="Disease" MappingType="XRef" MappingValue="256030" MappingRef="OMIM">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5002386" TraitType="Disease" MappingType="XRef" MappingValue="256030" MappingRef="OMIM">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9812053" TraitType="Disease" MappingType="XRef" MappingValue="619334" MappingRef="OMIM">
        <MedGen CUI="C5543431" Name="Arthrogryposis multiplex congenita 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2717844" TraitType="Disease" MappingType="XRef" MappingValue="C1850569" MappingRef="MedGen">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

